HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vitamin K status and vascular calcification: evidence from observational and clinical studies.

Abstract
Vascular calcification occurs when calcium accumulates in the intima (associated with atherosclerosis) and/or media layers of the vessel wall. Coronary artery calcification (CAC) reflects the calcium burden within the intima and media of the coronary arteries. In population-based studies, CAC independently predicts cardiovascular disease (CVD) and mortality. A preventive role for vitamin K in vascular calcification has been proposed based on its role in activating matrix Gla protein (MGP), a calcification inhibitor that is expressed in vascular tissue. Although animal and in vitro data support this role of vitamin K, overall data from human studies are inconsistent. The majority of population-based studies have relied on vitamin K intake to measure status. Phylloquinone is the primary dietary form of vitamin K and available supplementation trials, albeit limited, suggest phylloquinone supplementation is relevant to CAC. Yet observational studies have found higher dietary menaquinone, but not phylloquinone, to be associated with less calcification. Vascular calcification is highly prevalent in certain patient populations, especially in those with chronic kidney disease (CKD), and it is plausible vitamin K may contribute to reducing vascular calcification in patients at higher risk. Subclinical vitamin K deficiency has been reported in CKD patients, but studies linking vitamin K status to calcification outcomes in CKD are needed to clarify whether or not improving vitamin K status is associated with improved vascular health in CKD. This review summarizes the available evidence of vitamin K and vascular calcification in population-based studies and clinic-based studies, with a specific focus on CKD patients.
AuthorsM Kyla Shea, Rachel M Holden
JournalAdvances in nutrition (Bethesda, Md.) (Adv Nutr) Vol. 3 Issue 2 Pg. 158-65 (Mar 01 2012) ISSN: 2156-5376 [Electronic] United States
PMID22516723 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Calcium-Binding Proteins
  • Extracellular Matrix Proteins
  • Vitamins
  • matrix Gla protein
  • Vitamin K
  • Vitamin K 1
Topics
  • Adult
  • Aged
  • Animals
  • Calcium-Binding Proteins (metabolism, physiology)
  • Dietary Supplements
  • Evidence-Based Medicine
  • Extracellular Matrix Proteins (metabolism, physiology)
  • Female
  • Humans
  • Kidney Failure, Chronic (complications)
  • Male
  • Middle Aged
  • Vascular Calcification (complications)
  • Vitamin K (administration & dosage)
  • Vitamin K 1 (administration & dosage)
  • Vitamins (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: